Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorOslo University Hospital
About this trial
This prospective clinical cohort study will follow 40 patients who recieve botulinum toxin A treatment for proximal medial gastrocnemius tightness with subsequent Chronic Plantar Fasciitis for two years. Three injections of botulinum toxin (75IU) will be administered with intervals of three months. Participants will be followed at baseline, 3 months, 6 months, 1 year and 2 years with Patient Related Outcome Measures (PROMS) and physical test (Ergotest and ankle dorsiflexion).
Eligibility criteria
Qualifiers
Age 18-75 years.
An isolated gastrocnemius contracture must be verified with the Silfverskiölds test before inclusion.
Diagnosis plantar fasciitis verified clinically by an orthopaedic surgeon.
Diagnosis verified by MRI. MRI criteria: Thickening of the plantar fascia, oedema in the calcaneus, pathological signal changes in the plantar fascia (35)
Disqualifiers
Previously undergone surgery for plantar fasciitis.
Patients with severe talocrural pathology or serious malalignment of foot and ankle
Severely reduced peripheral circulation
History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
Trial design
Treatments tested in this trial
- Botox
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov